GENOSS® DES Sirolimus Eluting Coronary Stent System

DEVICE2 trials

Sponsors

Genoss Co., Ltd.

Conditions

Coronary Artery DiseaseMultivessel Coronary Artery DiseasePercutaneous Coronary Intervention

Unknown Phase

Effectiveness and Safety of Abluminal Biodegradable Polymer Sirolimus-eluting Stent (GENOSS® DES)

Enrolling by invitationNCT06086496

Genoss Co., Ltd.Coronary Artery Disease, Percutaneous Coronary Intervention

Start: 2022-07-15End: 2027-12-31Target: 1000Updated: 2025-10-06

Safety and Effectiveness of GENOSS® DES in Patients With Multivessel Coronary Artery Disease

Enrolling by invitationNCT06168305

Genoss Co., Ltd.Multivessel Coronary Artery Disease, Percutaneous Coronary Intervention

Start: 2023-11-15End: 2028-02-28Target: 1000Updated: 2025-10-06